Predicting treatment outcome following 24 weeks peginterferon α-2a/ribavirin therapy in patients infected with HCV genotype 1: Utility of HCV-RNA at Day 0, Day 22, Day 29, and Week 6 [3]

2007

Hepatology , Volume 45 - Issue 1 p. 258- 259

Additional Metadata
Persistent URL	doi.org/10.1002/hep.21505, hdl.handle.net/1765/35980
Journal	Hepatology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Lukasiewicz, E., Hellstrand, K., Westin, J., Ferrari, C., Neumann, A., Pawlotsky, J.-M., … Lagging, M. (2007). Predicting treatment outcome following 24 weeks peginterferon α-2a/ribavirin therapy in patients infected with HCV genotype 1: Utility of HCV-RNA at Day 0, Day 22, Day 29, and Week 6 [3]. Hepatology, 45(1), 258–259. doi:10.1002/hep.21505

Publication